FDA leaders under President Donald Trump are moving to abandon a decades-old policy of asking outside experts to review drug applications, a move critics say would shield the agency’s decisions from public scrutiny. The agency “would like to get away” from assembling panels of experts to examine and vote on individual drugs, because “I don’t…
New moms all over social media are breaking down their incredibly expensive hospital bills after giving birth. So why is giving birth so pricey in the U.S.? And given the Trump administration’s anti-abortion, pro-natalist policies, is anything on the table to make having a child more affordable? KFF Health News video producer Hannah Norman spoke…
By KIM BELLARD I’m always on the lookout for advances in healthcare that seem more like 22st century medicine than what we still experience in 2025. Way too much of it seems less advanced than we should be expecting in a world of AI, genetic engineering, nanobots, and the like. I often think of the…
A paper in Value in Health by Grueger, Martin and Sullivan (2025) provides some lessons. Together with widespread digitalization of drug compendia (price lists), IRP led to a rapid convergence of list prices across Europe. Although prices often spread ±50% from the average price for drugs first launched in the EU in 1997, this narrowed…
Headway has expanded its EHR system to include an AI-assisted notes feature and an integrated telehealth capability. The post Headway Launches Enhanced EHR Platform for Mental Health Providers appeared first on MedCity News.
The clinical decision support market is evolving quickly. With heavy investor backing and competing strategies around specialization, data depth and distribution, the coming years will determine which companies emerge as lasting leaders at the point of care. The post Inside the Clinical Decision Support Market: The Race to Make AI Work at the Point of…
The Host Julie Rovner KFF Health News @jrovner @julierovner.bsky.social Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health policy news podcast, “What the Health?” A noted expert on health policy issues, Julie is the author of the critically praised reference book “Health Care Politics and Policy A…
This budget summary provides an analysis of global health funding amounts provided in the House FY 2026 Labor, Health and Human Services, Education, and Related Agencies (Labor HHS) appropriations bill and accompanying report.
LB Pharmaceuticals found enough investor interest to boost the size of its IPO, which will finance clinical trials in schizophrenia and bipolar depression. The biotech has modified an old Sanofi drug with changes intended to reduce side effects and allow less frequent dosing. The post LB Pharma Pushes the Biotech IPO Window Open, Bagging $285M…
In his latest column for the JAMA Health Forum, KFF’s Larry Levitt talks about how popular shows like “The Pitt” can make changes to the health care system stemming from this year’s federal tax and budget bill tangible for viewers, and offers some suggested story lines.